Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis
- 1 January 2001
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 21 (1) , 25-32
- https://doi.org/10.2165/00044011-200121010-00004
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Allergic Rhinitis: Epidemiology and Natural HistoryAllergy and Asthma Proceedings, 2000
- Induction and regulation of the IgE responseNature, 1999
- Safety and Efficacy of Once-Daily Fexofenadine HCl in the Treatment of Autumn Seasonal Allergic RhinitisAllergy and Asthma Proceedings, 1999
- EVALUATION AND MANAGEMENT OF ALLERGIC RHINITISMedical Clinics of North America, 1999
- Effectiveness and Safety of Fexofenadine, a New Nonsedating H1-Receptor Antagonist, in the Treatment of Fall AllergiesAllergy and Asthma Proceedings, 1998
- Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit☆☆☆★★★Journal of Allergy and Clinical Immunology, 1998
- Treating Allergic Rhinitis with Second‐Generation AntihistaminesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1996
- Comparative Study of Cetirizine and Terfenadine Versus Placebo in the Symptomatic Management of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1996
- Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1988